hemophilianewstoday3h
What it’s like managing hemophilia with an inhibitor, part 2
The treatment landscape for hemophilia with an inhibitor has changed drastically in recent years, columnist Cazandra Campos-MacDonald says.
hemophilianewstoday1d
Bleeding Disorders Awareness Month features education, advocacy
March is Bleeding Disorders Awareness Month, and advocates are working together to call attention to the conditions.
hemophilianewstoday1d
What to do when sexual intimacy and bleeding disorders collide
Some women experience extremely heavy bleeding during sexual intimacy, and we need to talk about it more, says columnist.
hemophilianewstoday2d
In our family, action is the antidote to fear
Columnist Alliah Czarielle has been thinking a lot lately how action is the antidote to fear for her husband, who lives with hemophilia.
hemophilianewstoday5d
What’s next after Pfizer’s gene therapy for hemophilia B is halted?
Columnist Jennifer Lynne assesses the effects of Pfizer's decision to halt production of its hemophilia B gene therapy, Beqvez.
hemophilianewstoday5d
Pfizer discontinues hemophilia B treatment Beqvez
Pfizer said it will discontinue gene therapy Beqvez (fidanacogene elaparvovec-dzkt), an approved hemophilia B treatment.
hemophilianewstoday5d
Marisa Wexler, MS, senior science writer—
The Loma Linda University Health (LLUH) Hemophilia Treatment Center has become the first clinic in California offering Hympavzi (marstacimab) for people with hemophilia B. “For the first time, ...
hemophilianewstoday6d
My family is enjoying a respite from complications of hemophilia
It's been several months since his sons have experienced complications of hemophilia, and columnist Joe MacDonald is grateful but anxious.